Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.
Soriano
V
V
Barreiro
P
P
Gonzalez-Lahoz
J
J
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D019888:Nelfinavir / Q000627:therapeutic use*; D009570:Nitriles / Q000627:therapeutic use*; D011446:Prospective Studies; D011759:Pyrrolidines / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D019258:Saquinavir / Q000627:therapeutic use*; D018119:Stavudine / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
C121834:1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine; D019380:Anti-HIV Agents; D009570:Nitriles; D011759:Pyrrolidines; D019259:Lamivudine; D018119:Stavudine; D019888:Nelfinavir; D019258:Saquinavir